Abstract
The introduction will explain the scope of the book: (i) the presentation of clinical evidence for the efficacy of herbal and nutritional treatments in the context of anxiety disorders, and (ii) how health professionals can apply this knowledge in a clinical setting with patients presenting with a wide range of symptoms, including comorbid mood disorders. The rationale for using these treatments in comparison to pharmaceutical options is also discussed, including a more favourable side effect profile and multi-modal mechanisms of action that make these treatments more suitable as chronic treatments.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Australian Bureau of Statistics. National Survey of Mental Health and Wellbeing: summary of results, 2007. Canberra: ABS; 2007.
Slade T et al. 2007 National Survey of Mental Health and Wellbeing: methods and key findings. Aust N Z J Psychiatry. 2009;43(7):594–605.
Kessler RC et al. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21(3):169–84.
Barlow DH. Anxiety and its disorders: the nature and treatment of anxiety and panic. New York: Guilford Press; 1988.
Degenhardt L, Topp L. ‘Crystal meth’ use among polydrug users in Sydney’s dance party subculture: characteristics, use patterns and associated harms. Int J Drug Policy. 2003;14(1):17–24.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-5). 5th ed. Washington, DC: American Psychiatric Association; 2013.
Otto MW, McHugh RK, Kantak KM. Combined pharmacotherapy and cognitive-behavioral therapy for anxiety disorders: medication effects, glucocorticoids, and attenuated treatment outcomes. Clin Psychol(Science and Practice). 2010;17(2):91–103.
Read J, Cartwright C, Gibson K. Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Res. 2014;216(1):67–73.
Baldwin D et al. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ. 2011;342.
Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis. J Clin Psychopharmacol. 2009;29(3):259–66.
Lam RW. Sleep disturbances and depression: a challenge for antidepressants. Int Clin Psychopharmacol. 2006;21(Suppl 1):S25–9.
Serretti A, Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry. 2010;71(10):1259–72.
Hofmann SG et al. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cognit Thera Res. 2012;36(5):427–40.
Hofmann SG, Smits JAJ. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008;69(4):621–32.
Olatunji BO, Cisler JM, Deacon BJ. Efficacy of cognitive behavioral therapy for anxiety disorders: a review of meta-analytic findings. Psychiatr Clin North Am. 2010;33(3):557–77.
Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL. Trends in the Use of Complementary Health Approaches Among Adults: United States, 2002–2012. National health statistics reports. 2015;(79):1–16.
Spinks J, Hollingsworth B. Policy implications of complementary and alternative medicine use in Australia: Data from the National Health Survey. The Journal of Alternative and Complement Medicine. 2012;18(4):371–378. http://doi.org/10.1089/acm.2010.0817.
Zhang AL et al. A population survey on the use of 24 common medicinal herbs in Australia. Pharmacoepidemiol Drug Saf. 2008;17(10):1006–13.
McIntyre E et al. Herbal medicine use behaviour in Australian adults who experience anxiety: a descriptive study. BMC Complement Altern Med. 2016;16:60.
McIntyre E et al. Prevalence and predictors of herbal medicine use in adults experiencing anxiety: a critical review of the literature. Adv Intern Med. 2015;2(1):38–48.
Pirotta M et al. Complementary medicine in general practice a national survey of GP attitudes and knowledge. Aust Fam Physician. 2010;39:946–50.
Zhang Y et al. Discrepancy between patients use of and health providers familiarity with CAM. Patient Educ Couns. 2012;89(3):399–404.
Heinrich M et al. Fundamentals of pharmacognosy and phytotherapy. London: Churchill Livingstone; 2004.
Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine. 2001;8:401–9.
Bensky D, Gamble A. Chinese herbal formulas. Seattle: Eastland Press; 1991.
Camfield DA. Herbal extracts and cognition in adulthood and ageing. In: Riby LM, Smith MA, Foster JK, editors. Nutrition and mental performance – a lifespan perspective. Hampshire, UK: Palgrave Macmillan; 2012.
Groot MJ, Van Der Roest J. Quality control in the production chain of herbal products. In: Bogers RJ, Craker LE, Lange D, editors. Medicinal and aromatic plants. The Netherlands: Springer; 2006. p. 253–60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Camfield, D.A., McIntyre, E., Sarris, J. (2017). The Need for Evidence-Based Herbal and Nutritional Anxiety Treatments in Psychiatry. In: Camfield, D., McIntyre, E., Sarris, J. (eds) Evidence-Based Herbal and Nutritional Treatments for Anxiety in Psychiatric Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-42307-4_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-42307-4_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-42305-0
Online ISBN: 978-3-319-42307-4
eBook Packages: MedicineMedicine (R0)